Practical Guide to EU Funding for Research, Development & Innovation

The EU supports research and innovation activities through a range of programmes, including the Seventh Framework Programme for Research (FP7), the Competitiveness and Innovation Programme (CIP) and Structural Funds. Now the European Commission is developing a guide to help researchers select the right programme for their activities and even combine funds from different sources. A draft version of the guide is now ready and the Commission is keen to receive feedback on the document from the research community.

At the heart of the guide is a six-point checklist designed to help researchers identify the most relevant funding source for their needs. Questions cover the eligibility of the organisation or company, the eligibility of the planned activity, the timeframe for the project, the type of financial support needed and the identity of any other partners involved.

With a budget of over €50 billion for the period 2007 to 2013, FP7 is the EU's main instrument for the support of research and development activities. Meanwhile the €3.6 billion CIP initiative aims to boost the competitiveness of European businesses, with a focus on eco-innovation, information and communication technologies (ICTs) and renewable energies and energy efficiency.

Structural Funds are designed to reduce disparities in the level of development among regions and Member States. Although the amount of funding allocated to research and innovation varies from region to region, it is estimated that the total amount allocated to these activities will top the €99 billion mark for the period 2007 to 2013.

The guide explains how funds from these three sources can be combined to best effect, without falling foul of co-financing rules (which require recipients of most EU funds to finance part of their project from non-EU sources). The trick, according to the guide, is to use complementary financing.

"For example, separate but related activities or parts of a project can be funded by the Structural Funds, FP7 or the CIP," the guide reads. "Equally, the different funding sources may support different phases of the development of a technology over time, starting from basic research, to applied research, to demonstration or to pre-competitive market introduction."

A series of examples illustrates how different organisations might draw on different funds for different activities or phases of their projects.

The guide also notes that now is a good time to combine funds from these three sources. They share a common timeframe (2007 to 2013), and thanks to the Lisbon Strategy, research and innovation are now seen as crucial for regional development, a fact which is reflected in the Structural Funds. At the same time, the role of the regions in research is taken into account in both FP7 and CIP.

The Commission is keen to receive comments and suggestions by the end of April on how the guide can be made even more practical and user-friendly. Once finalised, the online version of the guide will be updated regularly and will also include links to the relevant national and regional programmes.

For further information, and a copy of the draft Practical Guide, please visit:
http://cordis.europa.eu/eu-funding-guide/home_en.html

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...